Qingdao Vland Biotech INC. (SHA:603739)
12.93
-0.17 (-1.30%)
Sep 2, 2026, 2:09 PM CST
SHA:603739 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 230.28 | 244.16 | 248.73 | 239.6 | 213.87 | 311.83 |
Trading Asset Securities | 241.83 | 224.87 | 199.34 | 292.05 | 212.02 | 170.43 |
Cash & Short-Term Investments | 472.11 | 469.02 | 448.07 | 531.64 | 425.89 | 482.27 |
Cash Growth | 34.80% | 4.68% | -15.72% | 24.83% | -11.69% | 38.83% |
Accounts Receivable | 446.49 | 409.27 | 376.58 | 330.26 | 307.72 | 254.31 |
Other Receivables | 38.53 | 41.97 | 28.68 | 25.83 | 32.51 | 36.3 |
Receivables | 485.03 | 460.24 | 405.26 | 356.09 | 347.91 | 298.37 |
Inventory | 242.86 | 226.37 | 188.95 | 205.41 | 173.63 | 157.02 |
Prepaid Expenses | - | 0 | 1.59 | 0.12 | 0.13 | 0.06 |
Other Current Assets | 38.5 | 22.98 | 25.31 | 30.68 | 21.84 | 34.1 |
Total Current Assets | 1,238 | 1,179 | 1,069 | 1,124 | 969.4 | 971.82 |
Property, Plant & Equipment | 1,473 | 1,524 | 1,560 | 1,505 | 1,260 | 843.51 |
Long-Term Investments | 15.34 | 76.25 | 98.64 | 80.84 | 77.19 | 8.59 |
Goodwill | 84.2 | 84.2 | 84.2 | 84.2 | 20.26 | 20.26 |
Other Intangible Assets | 137.88 | 126.72 | 131.13 | 139.74 | 135.63 | 131.46 |
Long-Term Deferred Tax Assets | 24.13 | 23.55 | 16.99 | 18.06 | 13.64 | 12.03 |
Long-Term Deferred Charges | 1.21 | 1.26 | 1.47 | 1.41 | 1.28 | 0.37 |
Other Long-Term Assets | 41.28 | 25.54 | 19.14 | 80.57 | 101.57 | 233.72 |
Total Assets | 3,016 | 3,040 | 2,981 | 3,034 | 2,579 | 2,222 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 207.01 | 194.41 | 224.56 | 231.95 | 147.36 | 112.11 |
Accrued Expenses | 27.09 | 116.92 | 102.09 | 91.76 | 74.26 | 72.89 |
Short-Term Debt | 602.99 | 582.87 | 581.63 | 568.97 | 374.22 | 135.93 |
Current Portion of Long-Term Debt | 15.94 | 36.12 | 40.03 | 92.88 | - | 1 |
Current Income Taxes Payable | 16.96 | 8.34 | 10.06 | 8.43 | 11.67 | 8.95 |
Current Unearned Revenue | 19.04 | 14.25 | 11.51 | 10.67 | 7.49 | 13.62 |
Other Current Liabilities | 112.96 | 54.17 | 61.57 | 83.51 | 30.1 | 27.83 |
Total Current Liabilities | 1,002 | 1,007 | 1,031 | 1,088 | 645.09 | 372.33 |
Long-Term Debt | 49.91 | 59.79 | 13.96 | 62.06 | 149 | 99 |
Long-Term Unearned Revenue | 52.89 | 59.58 | 63.97 | 55.26 | 47.96 | 60.45 |
Long-Term Deferred Tax Liabilities | 1.34 | 1.38 | 1.46 | 3.02 | 2.72 | 2.88 |
Other Long-Term Liabilities | 1.11 | 1.11 | 0.15 | 0.15 | 0.17 | 1.52 |
Total Liabilities | 1,107 | 1,129 | 1,111 | 1,209 | 844.93 | 536.18 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 253.03 | 253.03 | 253.03 | 253.03 | 252.44 | 252.08 |
Additional Paid-In Capital | 702.9 | 702.9 | 702.9 | 712.08 | 705.09 | 693.84 |
Retained Earnings | 854.66 | 841.4 | 796.9 | 759.56 | 704.12 | 674.61 |
Comprehensive Income & Other | -14.8 | -14.81 | -15.1 | -16.38 | -16.96 | -16.03 |
Total Common Equity | 1,796 | 1,783 | 1,738 | 1,708 | 1,645 | 1,605 |
Minority Interest | 112.9 | 128.2 | 132.3 | 117.09 | 89.22 | 81.07 |
Shareholders' Equity | 1,909 | 1,911 | 1,870 | 1,825 | 1,734 | 1,686 |
Total Liabilities & Equity | 3,016 | 3,040 | 2,981 | 3,034 | 2,579 | 2,222 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 668.83 | 678.78 | 635.62 | 723.92 | 523.22 | 235.93 |
Net Cash (Debt) | -196.72 | -209.76 | -187.55 | -192.27 | -97.33 | 246.34 |
Net Cash Growth | - | - | - | - | - | -11.88% |
Net Cash Per Share | -0.77 | -0.84 | -0.75 | -0.76 | -0.38 | 1.00 |
Filing Date Shares Outstanding | 258.88 | 253.03 | 253.03 | 253.03 | 252.62 | 252.08 |
Total Common Shares Outstanding | 258.88 | 253.03 | 253.03 | 253.03 | 252.44 | 252.08 |
Working Capital | 236.52 | 171.53 | 37.75 | 35.77 | 324.31 | 599.5 |
Book Value Per Share | 6.94 | 7.04 | 6.87 | 6.75 | 6.52 | 6.36 |
Tangible Book Value | 1,574 | 1,572 | 1,522 | 1,484 | 1,489 | 1,453 |
Tangible Book Value Per Share | 6.08 | 6.21 | 6.02 | 5.87 | 5.90 | 5.76 |
Buildings | - | 1,009 | 932.34 | 931.6 | 449.85 | 398.83 |
Machinery | - | 1,095 | 943.65 | 929.21 | 474.19 | 443.58 |
Construction In Progress | - | 37.4 | 203.81 | 75.14 | 704.43 | 315.72 |